Searched for
SAI LIFE SCIENCES
Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Shares worth $26 billion can soon hit market as IPO lock-ins endApproximately $26 billion in shares from 71 recently listed companies will become available for sale as IPO lock-ins expire between June 17...
- Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities ended sharply lower as weak global cues and geopolitical tensions triggered broad-based selling. Nifty slipped 1.04% to 23,...
- Ahead of Market: 10 things that will decide D-Street action on MondayIndian benchmark indices ended marginally lower on Friday as investors assessed the RBI’s decision to keep rates unchanged while raising in...
- IPO investors brace for 70 lock-in expiries worth $35 billion in three months. Do you own any?According to Nuvama Alternative & Quantitative Research, the Indian stock market is set to witness a significant wave of lock-in expiries b...
- Nifty stuck in a range but small and midcaps are where real money is being made: Ashish ChaturmohtaIndian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial's Ashish Chaturmohta highlights ...
- IPO investors brace for 73 lock-in expiries worth $34 billion in three months. Will your portfolio be impacted?India’s stock market is set for a wave of IPO lock-in expiries over the next three months, with shares worth $34 billion from 73 recently l...
- Local legal eagles answer the 130-billion-dollar questionsIndian law firms are busier than ever, advising on thousands of deals worth billions. This activity spans mergers, private equity, and vent...
- India's urban transformation must be backed by accountability: CAG at BRICS SAI SummitDuring the BRICS Summit in Bengaluru, K Sanjay Murthy, India's chief auditor, emphasized the urgent call for heightened accountability in u...
- Sai Life Sciences shares drop 4% as TPG Asia likely offloads Rs 2,811 cr worth shares via block dealSai Life Sciences' shares experienced a 4% drop following a significant trade involving 3.2 crore shares. TPG Asia likely divested a 15.4% ...
- Stock Radar: Sai Life Sciences rallies over 20% in 3 months to hit record highs in July; time to buy or book profits?Sai Life Sciences has surged over 20% in the past three months, reaching a new high in July 2025. Technical indicators suggest continued bu...
- Sai Life Sciences shares list at 18% premium over IPO priceSai Life Sciences shares debuted with a premium on NSE and BSE, exceeding market expectations. The IPO saw strong demand from institutional...
- Sai Life Sciences IPO Day 1: Issue subscribed 84% led by QIBs. Check GMP, other key detailsThe IPO of the contract research and manufacturing firm opened for subscription on Wednesday, achieving 84% overall subscription on the fir...
- Sai Life Sciences IPO opens tomorrow. Check latest GMP, price band, key datesSai Life Sciences' unlisted shares traded at Rs 577 on Tuesday in the grey market, indicating a 5.1% premium over the IPO price band’s uppe...
- Sai Life Sciences IPO opens this week. GMP, price band, key dates among 10 things to knowSai Life Sciences' IPO, aiming to raise up to Rs 3,042 crore, includes a fresh equity issue of up to Rs 950 crore and an Offer for Sale of ...
- Sai Life Sciences files draft papers for nearly Rs 5,000 crore IPOThe company plans to raise funds through an offer of equity shares (face value Re 1 each) through initial public offerings. The offer compr...
Load More
